101 related articles for article (PubMed ID: 1355642)
1. [Chronic myelogenous leukemia with blastic crisis in which expression of P-glycoprotein was associated with resistance to chemotherapy].
Utsunomiya A; Kuwazuru Y; Chuman Y; Mishige Y; Saito T; Terada A; Iwahashi M; Hanada S; Yoshimura A; Akiyama S
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1915-8. PubMed ID: 1355642
[TBL] [Abstract][Full Text] [Related]
2. Expression of the multidrug transporter, P-glycoprotein, in chronic myelogenous leukaemia cells in blast crisis.
Kuwazuru Y; Yoshimura A; Hanada S; Ichikawa M; Saito T; Uozumi K; Utsunomiya A; Arima T; Akiyama S
Br J Haematol; 1990 Jan; 74(1):24-9. PubMed ID: 1968762
[TBL] [Abstract][Full Text] [Related]
3. Plicamycin-hydroxyurea association in chronic granulocytic leukemia and multidrug resistance.
Papineschi F; Carulli G; Petrini M
Haematologica; 1991; 76(4):349. PubMed ID: 1686602
[No Abstract] [Full Text] [Related]
4. [P-glycoprotein and treatment with plicamycin + hydroxyurea in myeloid blastic crisis of chronic myeloid leukemia].
Carulli G; Marini A; Caracciolo F
Medicina (Firenze); 1989; 9(4):409-10. PubMed ID: 2576761
[TBL] [Abstract][Full Text] [Related]
5. Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal.
Nüssler V; Pelka-Fleischer R; Zwierzina H; Nerl C; Beckert B; Gullis E; Gieseler F; Bock S; Bartl R; Petrides PE
Ann Hematol; 1994; 69 Suppl 1():S25-9. PubMed ID: 7914749
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia.
Carulli G; Petrini M; Marini A; Vaglini F; Caracciolo F; Grassi B
Haematologica; 1990; 75(6):516-21. PubMed ID: 1982999
[TBL] [Abstract][Full Text] [Related]
7. Chronic myelogenous leukemia in chronic phase transforming into acute leukemia under treatment with dasatinib 4 months after diagnosis.
Nakamura Y; Tokita K; Nagasawa F; Takahashi W; Nakamura Y; Sasaki K; Ichikawa M; Mitani K
Int J Hematol; 2016 Mar; 103(3):348-53. PubMed ID: 26662559
[TBL] [Abstract][Full Text] [Related]
8. Idarubicin in blastic crisis of chronic myelogenous leukemia.
Lambertenghi-Deliliers G; Annaloro C; Cortellaro M; Pozzoli E; Oriani A; Polli EE
Haematologica; 1991; 76(5):406-8. PubMed ID: 1806446
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy of chronic myelogenous leukemia--VP(M) regimen initiated during its chronic phase, and evaluation of MCNU in the phase of blastic crisis].
Kitajima K; Adachi T; Takahashi I; Nakada H; Osada K; Fukuda S; Ohmoto E; Aoyama S; Yorimitsu S; Sanada H
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3573-9. PubMed ID: 2817908
[TBL] [Abstract][Full Text] [Related]
10. Expression of a multidrug resistance gene in blast crisis of chronic myelogenous leukemia.
Pirker R; Goldstein LJ; Ludwig H; Linkesch W; Lechner C; Gottesman MM; Pastan I
Cancer Commun; 1989; 1(2):141-4. PubMed ID: 2639725
[TBL] [Abstract][Full Text] [Related]
11. [The changes of mRNAs of both c-myc and MDR1 in CML-bc tumor cells during the clinical course: a case report].
Kaida S; Fujikawa T; Endou S; Inaba S; Nagayama Y; Sakato H; Yamazaki Y; Sano S; Tanaka N; Yamada H
Rinsho Ketsueki; 1989 May; 30(5):697-701. PubMed ID: 2795883
[TBL] [Abstract][Full Text] [Related]
12. [Myeloid crisis of chronic myelogenous leukemia showing dramatic response to mithramycin and hydroxyurea combination].
Ueki K; Tsuchida A; Murakami H; Karasawa M; Kobayashi N; Omine M; Naruse T
Rinsho Ketsueki; 1989 Oct; 30(10):1840-2. PubMed ID: 2531808
[TBL] [Abstract][Full Text] [Related]
13. Two consecutive spontaneous regressions to chronic phase in a patient with blastic transformation of chronic myelogenous leukemia.
Cağirgan S; Sencan M; Tombuloglu M; Ozdemir E; Hekimgil M; Büyükkeçeci F
Leuk Lymphoma; 1998 Apr; 29(3-4):423-5. PubMed ID: 9684940
[TBL] [Abstract][Full Text] [Related]
14. Chronic granulocytic leukemia in blastic crisis. Prognostic factors.
Sales V; Rojo J; Collazo J; Lagunas E; Aguilar E; Albisua L
In Vivo; 1991; 5(3):281-5. PubMed ID: 1893082
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy and imatinib-induced molecular remission in lymphoid blast crisis after 20 years of "untreated" chronic myeloid leukemia.
Koca E; Sevimli F; Cetiner D; Haznedaroglu IC; Sayinalp N; Büyükasik Y; Goker H; Ozcebe O
Am J Hematol; 2007 Apr; 82(4):333. PubMed ID: 17094091
[No Abstract] [Full Text] [Related]
16. Dasatinib combined with weekly administration of vincristine as effective therapy in sudden or resistant Ph+ lymphoid blast crisis of chronic myeloid leukaemia.
Breccia M; Serrao A; Salaroli A; Loglisci G; Zacheo I; Alimena G
Br J Haematol; 2012 Dec; 159(5):612-3. PubMed ID: 23043319
[No Abstract] [Full Text] [Related]
17. [A case of chronic myelogenous leukemia responding to imatinib mesilate (Glivec) after relapse of blastic crisis following allogeneic bone marrow transplantation].
Fujisawa S; Yano K; Kobayashi M
Gan To Kagaku Ryoho; 2003 Mar; 30(3):427-30. PubMed ID: 12669406
[TBL] [Abstract][Full Text] [Related]
18. The role of the MDR-1/P-170 mechanism in the development of multidrug resistance in chronic myeloid leukemia.
Weide R; Dowding C; Paulsen W; Goldman J
Leukemia; 1990 Oct; 4(10):695-9. PubMed ID: 1976871
[TBL] [Abstract][Full Text] [Related]
19. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
Neviani P; Santhanam R; Oaks JJ; Eiring AM; Notari M; Blaser BW; Liu S; Trotta R; Muthusamy N; Gambacorti-Passerini C; Druker BJ; Cortes J; Marcucci G; Chen CS; Verrills NM; Roy DC; Caligiuri MA; Bloomfield CD; Byrd JC; Perrotti D
J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597
[TBL] [Abstract][Full Text] [Related]
20. Blast crisis in chronic myelogenous leukemia remains a difficult therapeutic challenge.
Nand S; Barton K
Leuk Lymphoma; 2007 Feb; 48(2):215-6. PubMed ID: 17325875
[No Abstract] [Full Text] [Related]
[Next] [New Search]
